Dr. Nikolina Kastratovic of the Faculty of Medical Sciences at the University of Kragujevac, Serbia, was honored with the award for her outstanding project on the immunomodulatory effects of combustible and electronic cigarettes on human cells.
The MAGNIFICAT study, strongly advocated by Prof. Riccardo Polosa, will evaluate the effects of the combined use of conventional cigarettes and electronic cigarettes on human health, quantifying this impact by collecting samples, researching and describing the core of different levels of dual use on exposure to toxic substances and harm reduction, and using specific biomarkers, clinical endpoints, and behavioral correlations
The data from these works as a whole can be used to assess the impact in terms of risk/benefit ratio of the regular use of combustion-free products, assisting the efforts of public health authorities in encouraging smokers to quit, especially those who perceive their smoke-damaged smile as a barrier to personal health or work and social relationships.
The CoEHAR researcher Dr. Lia Emma will attend the 2024 edition of the CORESTA Congress which will take place in Edinburgh, Scotland - UK, from 13-17 October
In order to continue a positive collaboration with the partners, CoEHAR researchers organized the Annual Replica International Meeting which will be held at the Torre Biologica in Catania, Italy from 25th to 29th March.
This study, strongly advocated by Prof. Riccardo Polosa, aims to investigate the consequences of the combined use of conventional cigarettes and electronic cigarettes on human health.
The study found that the antismoking medication varenicline can increase rates of smoking abstinence without causing serious adverse events.
In their work “Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review”, researchers analyzed 16 studies from 20 publications: most of the studies showed no difference in respiratory parameters. This indicates that electronic nicotine delivery systems substitution for smoking likely does not result in additional harm to respiratory health.
Replica researchers performed a standard toxicology battery of three assays used for product assessment and regulatory applications.
The DiaSmokeFree Working Group send a letter to the American Diabetes Association (ADA) expressing concern and seeking correction of a couple of statements in the ADA guidelines regarding the use…
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.